USPTO serial 97740693
MY KINHARTO PATIENT SUPPORT SERVICES
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SINGH, DEEP K
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with MY KINHARTO PATIENT SUPPORT SERVICES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*
Plus Government fees of $750
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA, US
South San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Brett Heavner
B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP901 NEW YORK AVENUE, NWWASHINGTON, DC 20001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Printed materials, namely, newsletters in the field of cardiovascular diseases and conditions, speaker communications in the nature of printed articles in the field of cardiovascular diseases and conditions, magazines in the field of cardiovascular diseases and conditions, catalogues in the field of cardiovascular diseases and conditions, posters, informational flyers featuring cardiovascular diseases and conditions, brochures in the field of cardiovascular diseases and conditions, pamphlets in the field of cardiovascular diseases and conditions, graphical prints, and graphical representations in relation to information regarding cardiovascular conditions and patient support programs | ACTIVE | — |
| 035 | providing information about medical records coding, billing, and compliance for patients with cardiac conditions for use by healthcare providers, patients, and caregivers | ACTIVE | — |
| 036 | Providing financial information about reimbursement for medical expenses for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; providing insurance information about medical benefit verification and prior authorization services for patients with cardiac conditions for use by healthcare providers, patients, and caregivers | ACTIVE | — |
| 041 | Education services, namely, providing webinars, seminars, and conferences in the field of cardiac diseases; classes to caregivers and patients regarding treatments and support for cardiovascular conditions | ACTIVE | — |
| 044 | Providing information services in the field of cardiac disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of heart diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of heart diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for heart diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of heart disease and conditions; Providing a website featuring educational information in the field of cardiovascular diseases and conditions about cardiac disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cytokinetics, Incorporated
- Other trademarks owned by Cytokinetics, Incorporated
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named MY KINHARTO PATIENT SUPPORT SERVICES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 1, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 1, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 1, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 2, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 2, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 2, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 15, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 14, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 14, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 9, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 9, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 9, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 9, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 4, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 2, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 2, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 13, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 27, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 27, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 27, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 18, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 23, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 23, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 28, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 7, 2023 | NWAP | NEW APPLICATION ENTERED | — |